SASLT practice guidelines: management of hepatitis C virus infection

MeSH terms

• Antiviral Agents / therapeutic use
• Blood Transfusion
• Drug Therapy, Combination
• Evidence-Based Medicine
• Genotype
• Hepatitis C / complications
• Hepatitis C / diagnosis
• Hepatitis C / epidemiology
• Hepatitis C / genetics
• Hepatitis C / therapy*
• Hepatitis C / transmission
• Hepatitis C, Chronic / diagnosis
• Hepatitis C, Chronic / therapy
• Humans
• Interferon alpha-2
• Interferon-alpha / adverse effects
• Interferon-alpha / therapeutic use
• Liver Cirrhosis / diagnosis
• Liver Cirrhosis / etiology
• Liver Function Tests
• Patient Care Team
• Polyethylene Glycols / adverse effects
• Polyethylene Glycols / therapeutic use
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Renal Dialysis / adverse effects
• Ribavirin / adverse effects
• Ribavirin / therapeutic use
• Risk Factors
• Saudi Arabia / epidemiology